AN OVERVIEW OF ANALYTICAL INSTRUMENT QUALIFICATION WITH REFERENCE OF PHARMACEUTICAL INDUSTRY
In the most general sense, validation refers to a process that consists of at least four distinct components or steps: software, instruments, methods or procedures, and system suitability The system, the software, and the method must all be validated, and system suitability is used to keep the process in check. But while the overall process is called validation, some of the steps also are referred to by that same term, as well as other steps such as qualification and verification. Analytical instruments are used for a specific analysis. So regular performance verifications are made to ensure that the instrument to be used is suitable for its intended application. All equipments used in the production of products shall be properly Validated and Calibrated to demonstrate that it is suitable for its intended purpose. The current equipment qualification programs and procedures used within the pharmaceutical industry are based on regulatory requirements, voluntary standards, vendor practices, and industry practices. The result is considerable variation in the way pharmaceutical companies approach the qualification of laboratory equipment and the way they interpret the often vague requirements. The process for instrument qualification follows the 4Qs model approach. It include design qualification (DQ), Installation qualification (IQ), Operational qualification (OQ), Performance qualification (PQ). The goal of any regulated laboratory is to provide reliable and valid data suitable for its intended purpose. Analysts use validated methods, system suitability tests, and in-process quality control checks to ensure that the data they acquire are reliable and that there are specific guidance and procedures available to ensure compliance.
Keywords: Qualification, FDA, Instruments, Validation, Calibration, Documentation
2. Maintenance and Calibration of Equipment, Code of Federal Regulations, Part 58.63, Title 21, Rev. April 2000.
3. Cloud PA. Validating a Laboratory Incubator, BioPharm 10 (11), 30–42, 1997.
4. Bedson P., The Development and Application of Guidance on Equipment Qualification of Analytical Instruments, Accred. Qual. Assur. 1 (6), 265–274, 1996.
5. Anjaneyulu Y, Marayya R, Quality Assurance and Quality Management in Pharmaceutical industry, Pharmabook Syndicate, 2005.
6. International Conference on Harmonization, Harmonized Tripartite Guideline, Validation of Analytical Procedures, Text and Methodology, Q2(R1), Nov. 2005.
7. International Conference on Harmonization. ICH Q2B: Validation of Analytical Procedures: Methodology. Federal Register. 1997; 62 FR 27463. http://www.fda.gov/cder/guidance/1320fnl.pdf.
8. US Food and Drug Administration. General Principles of Software Validation. Final Guidance for Industry and FDA Staff. Rockville, MD: US Department of Health and Human Services, Food and Drug Admini-stration, January, 2002.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).